Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

Market Cap	16.50B
Revenue (ttm)	4.05B
Net Income (ttm)	704.05M
Shares Out	825.93M
EPS (ttm)	0.83
PE Ratio	24.06
Forward PE	20.28
Dividend	0.35 (1.75%)
Ex-Dividend Date	May 29, 2025

Volume	25,230,316
Average Volume	37,853,686
Open	18.80
Previous Close	19.98
Day's Range	18.80 - 20.34
52-Week Range	10.50 - 20.58
Beta	-0.14
RSI	79.62
Earnings Date	Aug 27, 2025

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 3,869
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002020

Financial Performance

In 2024, SHE:002020's revenue was 4.16 billion, an increase of 3.99% compared to the previous year's 4.00 billion. Earnings were 711.96 million, an increase of 15.04%.